Fred Achecar, MD
Orthopaedic Surgery · Austell, GANPI 1447245394
Payments from drug & device makers
Across 40 payments — averaging $121.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UOC USA Inc$3K
- Omnilife Science, Inc$690
- Fidia Pharma USA Inc.$586
- Surgalign Spine Technologies, Inc.$262
- Smith+Nephew$139
- Bioventus LLC$134
- plus $106 from 5 others
Across 6 payments — averaging $1860.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Corin USA$6K
- Omnilife Science, Inc$5K
What the payments were for
- Consulting fees$1,62039%
- Food & beverage$2,55261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UOC USA Inc | 11 | $2,945 |
| Omnilife Science, Inc | 1 | $690 |
| Fidia Pharma USA Inc. | 15 | $586 |
| Surgalign Spine Technologies, Inc. | 2 | $262 |
| Smith+Nephew | 2 | $139 |
| Bioventus LLC | 1 | $134 |
| Zimmer Biomet | 2 | $47 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Avanos Medical | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Celonova Biosciences, Inc. | 3 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- U2, MDT$1,744
- U2$301
- TRILURON$300
- ALLOGRAFT$262
- U2, Disposable Trials$169
- U2 TKA, Conformity, USTARII$149
- CORI$135
- HIP7$135
- Exogen Ultrasound Bone Healing System$134
- Hymovis$128
- Hyalgan$128
- U2, PSA, UTF and U-Motion II$125
- MDT Trials, AiO$118
- U2, PSA, UTF, UTS, CONFORMITY, U-MOTION II, U-Star II$115
- CONFORMITY, U2$111
- U2, Conformity$111
How this compares
$4,862 in reported general payments places this provider in the 55th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 57 | $4,529 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 77 | $716 |
| Methylprednisolone | 115 | $503 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $210 |
| Cephalexin | 73 | $166 |
| Meloxicam | 40 | $80 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Austell
- Ali MortazaviAustell$254K
- Charles DecookCumming$48.3M
- Ormonde MahoneyAthens$10.8M
- Daxes BanitWarner Robins$5.7M
- John DorchakColumbus$3.8M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- George GuildCumming$1.4M
- Jon MinterAlpharetta$1.4M
- Tuan BuiLawrenceville$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.